Trial Profile
A Third Phase, Multicentre, Randomized as a Double Blind Study, Triple Placebo, Comparative of the Efficacy and Safety of an Association Secnidazol-Ciprofloxacin Compared With Amoxicillin-Clavulanic Acid for the Treatment of Uncomplicated Episode of Diverticular Sigmoiditis Among Adults
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ciprofloxacin (Primary) ; Secnidazole (Primary) ; Amoxicillin/clavulanic acid
- Indications Bacterial infections; Diverticulitis; Intra-abdominal infections
- Focus Therapeutic Use
- Acronyms DIVA
- 17 Dec 2012 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record NCT01733966.
- 17 Dec 2012 Status changed from recruiting to discontinued, according to ClinicalTrials.gov record NCT01733966.
- 21 Nov 2012 New source identified and integrated: ClinicalTrials.gov record NCT01733966.